---
layout: full_article
title: "Studi Molekuler Gen Penyandi Enzim Extended Spectrum ?-Lactamase (ESBL), ?-Lactamase AmpC, dan Karbapenemase pada Isolat Klinis Multi-drug Resistant (MDR) Klebsiella pneumoniae di RSUP Sanglah, Denpasar"
author: "GNR Suwardana, NMA Tarini, NND Fatmawati"
categories: eum
comments: true
---

<p><span class="font3">ISSN: 2303-1395 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;E-JURNAL MEDIKA, VOL. 8 NO.2,Februari,</span></p>
<p><span class="font3">2019</span></p>
<p><span class="font13" style="font-weight:bold;">I</span><span class="font0" style="font-weight:bold;">l—</span><span class="font4" style="font-variant:small-caps;">∖</span><span class="font1" style="font-variant:small-caps;">λλ λ &nbsp;</span><span class="font4" style="font-variant:small-caps;">∣</span><span class="font1" style="font-variant:small-caps;">directoryof</span></p>
<p><span class="font0" style="font-weight:bold;">OPEN ACCESS I__</span><span class="font1" style="font-weight:bold;font-style:italic;">f∖^Jf</span><span class="font0" style="font-weight:bold;">—∖U JOURNALS</span></p>
<p><span class="font12" style="font-weight:bold;">Studi Molekuler Gen Penyandi Enzim </span><span class="font12" style="font-weight:bold;font-style:italic;">Extended Spectrum β-</span></p>
<p><span class="font12" style="font-weight:bold;font-style:italic;">Lactamase</span><span class="font12" style="font-weight:bold;"> (ESBL), </span><span class="font12" style="font-weight:bold;font-style:italic;">β-Lactamase</span><span class="font12" style="font-weight:bold;"> AmpC, dan Karbapenemase pada Isolat Klinis </span><span class="font12" style="font-weight:bold;font-style:italic;">Multi-drug Resistant</span><span class="font12" style="font-weight:bold;"> (MDR) </span><span class="font12" style="font-weight:bold;font-style:italic;">Klebsiella pneumoniae</span><span class="font12" style="font-weight:bold;"> di RSUP Sanglah, Denpasar</span></p>
<p><span class="font10">GNR Suwardana</span><span class="font0" style="font-weight:bold;"><sup>1*</sup></span><span class="font10">, NMA Tarini</span><span class="font0" style="font-weight:bold;"><sup>2</sup></span><span class="font10">, NND Fatmawati</span><span class="font0" style="font-weight:bold;"><sup>2</sup></span></p>
<ul style="list-style:none;"><li>
<p><span class="font10">1. &nbsp;&nbsp;&nbsp;Program Studi Pendidikan Dokter FK UNUD</span></p></li>
<li>
<p><span class="font10">2. &nbsp;&nbsp;&nbsp;Departemen/SMF Mikrobiologi Klinik FK UNUD/RSUP Sanglah</span></p></li></ul>
<p><span class="font10">* </span><span class="font10" style="font-style:italic;">e-mail</span><span class="font10"> : </span><a href="mailto:rsi_suwardana@yahoo.com"><span class="font10">rsi_suwardana@yahoo.com</span></a></p><a name="caption1"></a>
<h2><a name="bookmark0"></a><span class="font10" style="font-weight:bold;"><a name="bookmark1"></a>ABSTRAK</span></h2>
<p><span class="font10" style="font-style:italic;">Klebsiella pneumoniae</span><span class="font10"> adalah salah satu bakteri penyebab </span><span class="font10" style="font-style:italic;">hospital acquired infections</span><span class="font10"> (HAIs) dengan angka morbiditas dan mortalitas yang tinggi. Tingginya beban kesehatan akibat infeksi </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> utamanya diakibatkan oleh sifat resistensi terhadap banyak golongan antibiotik (multi-resisten), termasuk resistensi terhadap antibiotik golongan mutakhir seperti sefalosporin generasi ketiga dan karbapenem. Tujuan penelitian ini adalah untuk mengonfirmasi keberadaan gen penyandi enzim </span><span class="font10" style="font-style:italic;">Extended Spectrum β-Lactamase</span><span class="font10"> (ESBL), </span><span class="font10" style="font-style:italic;">β-Lactamase</span><span class="font10"> AmpC, dan karbapenamase pada isolat klinis multi-resisten </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10">. Lima isolat klinis multi-resisten </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> terdeteksi secara fenotip menggunakan uji Vitek Compact 2 (Biomereux®), kemudian teknik </span><span class="font10" style="font-style:italic;">polymerase chain reaction</span><span class="font10"> (PCR) digunakan untuk mendeteksi adanya gen </span><span class="font10" style="font-style:italic;">bla</span><span class="font6" style="font-style:italic;">SHV</span><span class="font10" style="font-style:italic;">, bla</span><span class="font6" style="font-style:italic;">TEM</span><span class="font10" style="font-style:italic;">, bla</span><span class="font6" style="font-style:italic;">CTX-M</span><span class="font10"> sebagai gen penyandi ESBL, </span><span class="font10" style="font-style:italic;">bla</span><span class="font6" style="font-style:italic;">FOX</span><span class="font10"> sebagai gen penyandi AmpC, dan </span><span class="font10" style="font-style:italic;">bla</span><span class="font6" style="font-style:italic;">KPC</span><span class="font10"> serta </span><span class="font10" style="font-style:italic;">bla</span><span class="font6" style="font-style:italic;">NDM-1</span><span class="font10"> sebagai gen penyandi karbapenamase. Penelitian ini menemukan bahwa 4 dari 5 sampel positif memiliki gen penyandi ESBL, yakni 2 sampel dengan bla</span><span class="font6">CTX-M</span><span class="font10">, sedangkan 2 sampel lainnya didapatkan dual gen bla</span><span class="font6">SHV </span><span class="font10">dan bla</span><span class="font6">TEM</span><span class="font10">. Tidak ditemukan adanya gen penyandi AmpC maupun karbapenemase pada semua sampel. Sifat multi-resistensi pada isolat klinis </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> kemungkinan diakibatkan karena adanya gen penyandi </span><span class="font10" style="font-style:italic;">β-lactamase</span><span class="font10">, sedangkan resistensi terhadap karbapenem kemungkinan besar terjadi bukan karena adanya gen penyandi karbapenemase, namun dimungkinkan adanya mekanisme resistensi yang lain.</span></p>
<p><span class="font10" style="font-weight:bold;">Kata kunci </span><span class="font10">: </span><span class="font10" style="font-weight:bold;font-style:italic;">K. pneumoniae, multi-resistensi, ESBL, AmpC, karbapenemase</span></p>
<h2><a name="bookmark2"></a><span class="font10" style="font-weight:bold;"><a name="bookmark3"></a>ABSTRACT</span></h2>
<p><span class="font10" style="font-style:italic;">Klebsiella pneumoniae</span><span class="font10"> is type of bacteria that mainly caused </span><span class="font10" style="font-style:italic;">hospital acquired infections</span><span class="font10"> (HAIs) with high morbidity and mortality. </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> was termed as superbug due its multi-drug resistant profile to many common antibiotics, including the newest third generation of cephalosporin and carbapenem. This study was conducted to confirm the existence of resistance genes that encodes the </span><span class="font10" style="font-style:italic;">Extended Spectrum β-Lactamase</span><span class="font10"> (ESBL) enzymes, </span><span class="font10" style="font-style:italic;">β-Lactamase</span><span class="font10"> AmpC, and carbapenemase from clinical isolate multi-drug resistant </span><span class="font10" style="font-style:italic;">K. pneumoniae.</span><span class="font10"> Five </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> isolates with multi-drug resistant profiles were tested by Vitek Compact 2 (Biomereux®), then </span><span class="font10" style="font-style:italic;">polymerase chain reaction</span><span class="font10"> (PCR) was used to detect </span><span class="font10" style="font-style:italic;">bla</span><span class="font6" style="font-style:italic;">SHV</span><span class="font10" style="font-style:italic;">, bla</span><span class="font6" style="font-style:italic;">TEM</span><span class="font10" style="font-style:italic;">, bla</span><span class="font6" style="font-style:italic;">CTX-M</span><span class="font10"> genes that produce ESBL enzyme, </span><span class="font10" style="font-style:italic;">bla</span><span class="font6" style="font-style:italic;">FOX</span><span class="font10"> for</span></p>
<p><span class="font3">2019</span></p>
<p><span class="font13" style="font-weight:bold;">I</span><span class="font0" style="font-weight:bold;">l—∖/—∖ </span><span class="font1" style="font-variant:small-caps;">λ</span><span class="font0" style="font-weight:bold;"> j </span><span class="font1" style="font-variant:small-caps;">Directoryof </span><span class="font0" style="font-weight:bold;">OPEN ACCESS I_√ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;JOURNALS</span></p>
<p><span class="font10">AmpC</span><span class="font10" style="font-style:italic;">, bla</span><span class="font6" style="font-style:italic;">KPC</span><span class="font10"> and </span><span class="font10" style="font-style:italic;">bla</span><span class="font6" style="font-style:italic;">NDM-1</span><span class="font10"> genes for carbapenemase</span><span class="font6">. </span><span class="font10">This study found four samples were positive for ESBL genes (two samples with </span><span class="font10" style="font-style:italic;">bla</span><span class="font6" style="font-style:italic;">CTX-M</span><span class="font10"> and two with dual genes </span><span class="font10" style="font-style:italic;">bla</span><span class="font6" style="font-style:italic;">SHV</span><span class="font10"> and </span><span class="font10" style="font-style:italic;">bla</span><span class="font6" style="font-style:italic;">TEM</span><span class="font10">). All samples were negative for </span><span class="font10" style="font-style:italic;">bla</span><span class="font6" style="font-style:italic;">FOX</span><span class="font10" style="font-style:italic;">, bla</span><span class="font6" style="font-style:italic;">KPC</span><span class="font10" style="font-style:italic;">,</span><span class="font10"> dan </span><span class="font10" style="font-style:italic;">bla</span><span class="font6" style="font-style:italic;">NDM-1</span><span class="font10"> genes. </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10">’s multi-drug resistant profile might caused by the existance of gene that produces </span><span class="font10" style="font-style:italic;">β-lactamase</span><span class="font10">. Meanwhile, there are another mechanisms for carbapenem-resistant </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10">, beyond the existance of gene that encodes carbapanemase.</span></p>
<p><span class="font10" style="font-weight:bold;">Keywords : </span><span class="font9" style="font-weight:bold;font-style:italic;">K. pneumoniae, multi-drug resistant, ESBL, AmpC, carbapenemase</span></p>
<h2><a name="bookmark4"></a><span class="font10" style="font-weight:bold;"><a name="bookmark5"></a>PENDAHULUAN</span></h2>
<p><span class="font10">Salah satu spesies bakteri yang menjadi penyebab utama kasus-kasus </span><span class="font10" style="font-style:italic;">Hospital Acquired Infections</span><span class="font10"> (HAIs) adalah </span><span class="font10" style="font-style:italic;">Klebsiella pneumoniae</span><span class="font10">. Kasus HAIs akibat </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> menjadi salah satu faktor risiko meningkatnya angka morbiditas dan mortalitas pasien, memperpanjang waktu perawatan dan menambah pengeluaran biaya perawatan (</span><span class="font10" style="font-style:italic;">cost of expenditure</span><span class="font10">). </span><span class="font0" style="font-weight:bold;"><sup>1,2</sup></span></p>
<p><span class="font10">Tingginya beban kesehatan pada infeksi </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> terjadi karena sifat resistensi terhadap banyak golongan antibiotik atau sering disebut multi-resisten (</span><span class="font10" style="font-style:italic;">multi-drug resistant</span><span class="font10">). Sifat resistensi yang dimiliki oleh </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> umumnya disebabkan oleh enzim </span><span class="font10" style="font-style:italic;">Extended Spectrum β-Lactamase </span><span class="font10">(ESBL), dan </span><span class="font10" style="font-style:italic;">β-Lactamase</span><span class="font10"> AmpC yang mampu menghidrolisis antibiotik jenis β-Lactam.</span><span class="font0" style="font-weight:bold;"><sup>3</sup></span></p>
<p><span class="font10">Pada beberapa kasus infeksi berat akibat </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> penghasil ESBL atau AmpC, antibiotik yang menjadi</span></p>
<p><span class="font10">pilihan utama adalah karbapenem.</span><span class="font0" style="font-weight:bold;"><sup>2 </sup></span><span class="font10">Namun, beberapa laporan klinis menyebutkan adanya sifat resistensi terhadap karbapenem akibat produksi enzim karbapenemase yang juga mampu menghidrolisis antibiotik golongan karbapenem.</span><span class="font0" style="font-weight:bold;"><sup>4,5</sup></span></p>
<p><span class="font10">Keberadaan enzim-enzim yang mampu menghidrolisis banyak golongan antibiotik sangat penting untuk dikonfirmasi baik secara fenotip dan genotip, utamanya menyangkut pilihan terapi yang efektif bagi pasien serta surveilans kesehatan. Penelitian ini bertujuan untuk mengetahui keberadaan gen-gen penyandi ESBL, AmpC, dan karbapenemase pada isolat klinis </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> di RSUP Sanglah, Denpasar-Bali.</span></p>
<h2><a name="bookmark6"></a><span class="font10" style="font-weight:bold;"><a name="bookmark7"></a>BAHAN DAN METODE</span></h2>
<p><span class="font10">Penelitian ini merupakan penelitian eksperimen laboratorium dengan teknik potong lintang (</span><span class="font10" style="font-style:italic;">crosssectional</span><span class="font10">), dengan waktu penelitian</span></p>
<p><span class="font10">dimulai dari April hingga November 2015. Penelitian ini dilaksanakan di Instalasi Mikrobiologi Klinik RSUP Sanglah &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Laboratorium</span></p>
<p><span class="font10">Mikrobiologi Fakultas Kedokteran Universitas Udayana (FK UNUD).</span></p>
<p><span class="font10">Sampel pada penelitian ini menggunakan isolat </span><span class="font10" style="font-style:italic;">K. pneumoniae </span><span class="font10">dengan profil multi-resisten melalui uji Vitek Compact 2 (Biomeriux®) dari semua spesimen klinis yang diperoleh di Laboratorium Mikrobiologi Klinik</span></p>
<p><span class="font10">RSUP Sanglah tahun 2015. Sampel penelitian diambil dengan metode </span><span class="font10" style="font-style:italic;">consecutive sampling</span><span class="font10"> dengan jumlah isolat yang ditemukan sebanyak 5 isolat. Sampel </span><span class="font10" style="font-style:italic;">K. pneumonia</span><span class="font10"> dipastikan terlebih dahulu dengan mendeteksi gen 16s RNA, sedangkan gen resistensi yang diteliti pada penelitian ini yakni bla</span><span class="font6">SHV</span><span class="font10">, bla</span><span class="font6">TEM</span><span class="font10">, dan bla</span><span class="font6">CTX-M </span><span class="font10">sebagai penyandi ESBL, bla</span><span class="font6">FOX </span><span class="font10">sebagai penyandi AmpC, bla</span><span class="font6">KPC </span><span class="font10">dan bla</span><span class="font6">NDM-1 </span><span class="font10">sebagai penyandi gen karbapenamase.</span></p>
<table border="1">
<tr><td colspan="6" style="vertical-align:bottom;">
<p><span class="font10" style="font-weight:bold;">Tabel 1. </span><span class="font10">Deskripsi primer (16sRNA, bla</span><span class="font6">SHV</span><span class="font10">, bla</span><span class="font6">TEM</span><span class="font10">, bla</span><span class="font6">CTX-M</span><span class="font10">, bla</span><span class="font6">FOX</span><span class="font10">, bla</span><span class="font6">KPC</span><span class="font10">, dan bla</span><span class="font6">NDM-1</span><span class="font10">).</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font7">Gen</span></p></td><td style="vertical-align:middle;">
<p><span class="font7" style="font-style:italic;">Primer</span></p></td><td style="vertical-align:middle;">
<p><span class="font7" style="font-style:italic;">Sequence</span></p>
<p><span class="font7" style="font-style:italic;">Forward</span><span class="font7"> 5’→3’</span></p>
<p><span class="font7" style="font-style:italic;">Reverse</span><span class="font7"> 3’→5’</span></p></td><td style="vertical-align:middle;">
<p><span class="font7" style="font-style:italic;">Annealing </span><span class="font7">(waktu/suhu)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font7">Panjang Basa (</span><span class="font7" style="font-style:italic;">base pair</span><span class="font7">)</span></p></td><td style="vertical-align:middle;">
<p><span class="font7">Sitasi</span></p></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:bottom;">
<p><span class="font7" style="font-style:italic;">Forward</span></p></td><td style="vertical-align:bottom;">
<p><span class="font7">AGA GTT TGA TCM TGG CTC AG</span></p></td><td style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font7">1,5 kilo bp</span></p></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font7">16s RNA</span></p></td><td style="vertical-align:middle;">
<p><span class="font7" style="font-style:italic;">Reverse</span></p></td><td style="vertical-align:middle;">
<p><span class="font7">ACG GHT ACC TTG TTA CGA CTT</span></p></td><td style="vertical-align:top;">
<p><span class="font7">30 detik/55 <sup>o</sup>C</span></p></td><td style="vertical-align:top;">
<p><span class="font7">6</span></p></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:bottom;">
<p><span class="font7" style="font-style:italic;">Forward</span></p></td><td style="vertical-align:bottom;">
<p><span class="font7">ATG CGT TAT ATT CGC CTG TG</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font7" style="font-style:italic;font-variant:small-caps;">B</span><span class="font7" style="font-style:italic;">la</span><span class="font8" style="font-style:italic;font-variant:small-caps;">shv</span></p></td><td style="vertical-align:middle;">
<p><span class="font7" style="font-style:italic;">Reverse</span></p></td><td style="vertical-align:middle;">
<p><span class="font7">AGC GTT GCC AGT GCT CGA TC</span></p></td><td style="vertical-align:top;">
<p><span class="font7">30 detik/55 <sup>o</sup>C</span></p></td><td style="vertical-align:top;">
<p><span class="font7">862 bp</span></p></td><td style="vertical-align:top;">
<p><span class="font7">7,8</span></p></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:bottom;">
<p><span class="font7" style="font-style:italic;">Forward</span></p></td><td style="vertical-align:bottom;">
<p><span class="font7">ATG AGT ATT CAA CAT TTC CG</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font7" style="font-style:italic;font-variant:small-caps;">B</span><span class="font7" style="font-style:italic;">la</span><span class="font8" style="font-style:italic;font-variant:small-caps;">tem</span></p></td><td style="vertical-align:middle;">
<p><span class="font7" style="font-style:italic;">Reverse</span></p></td><td style="vertical-align:middle;">
<p><span class="font7">CCA ATG CTT ATT CAG TGA GG</span></p></td><td style="vertical-align:top;">
<p><span class="font7">60 detik/55 <sup>o</sup>C</span></p></td><td style="vertical-align:top;">
<p><span class="font7">858 bp</span></p></td><td style="vertical-align:top;">
<p><span class="font7">7,8</span></p></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:bottom;">
<p><span class="font7" style="font-style:italic;">Forward</span></p></td><td style="vertical-align:bottom;">
<p><span class="font7">SCS ATG TG CAGY ACC AGT AA</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font7" style="font-style:italic;font-variant:small-caps;">B</span><span class="font7" style="font-style:italic;">la</span><span class="font8" style="font-style:italic;font-variant:small-caps;">ctx-m</span></p></td><td style="vertical-align:middle;">
<p><span class="font7" style="font-style:italic;">Reverse</span></p></td><td style="vertical-align:middle;">
<p><span class="font7">ACC AGA AYV AGC GGB GC</span></p></td><td style="vertical-align:top;">
<p><span class="font7">60 detik/55 <sup>o</sup>C</span></p></td><td style="vertical-align:top;">
<p><span class="font7">585 bp</span></p></td><td style="vertical-align:top;">
<p><span class="font7">7,8</span></p></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:bottom;">
<p><span class="font7" style="font-style:italic;">Forward</span></p></td><td style="vertical-align:bottom;">
<p><span class="font7">AAC ATG GGG TAT CAG GGA GAT G</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font7" style="font-style:italic;font-variant:small-caps;">B</span><span class="font7" style="font-style:italic;">la</span><span class="font8" style="font-style:italic;font-variant:small-caps;">fox</span></p></td><td style="vertical-align:middle;">
<p><span class="font7" style="font-style:italic;">Reverse</span></p></td><td style="vertical-align:middle;">
<p><span class="font7">CAA AGC GCG TAA CCG GAT TGG</span></p></td><td style="vertical-align:top;">
<p><span class="font7">30 detik/55 <sup>o</sup>C</span></p></td><td style="vertical-align:top;">
<p><span class="font7">190 bp</span></p></td><td style="vertical-align:top;">
<p><span class="font7">9</span></p></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:bottom;">
<p><span class="font7" style="font-style:italic;">Forward</span></p></td><td style="vertical-align:bottom;">
<p><span class="font7">TCG AAC AGG ACT TTG GCG</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font7" style="font-style:italic;font-variant:small-caps;">B</span><span class="font7" style="font-style:italic;">la</span><span class="font8" style="font-style:italic;font-variant:small-caps;">kpc</span></p></td><td style="vertical-align:middle;">
<p><span class="font7" style="font-style:italic;">Reverse</span></p></td><td style="vertical-align:middle;">
<p><span class="font7">GGA ACC AGC GCA TTT TTG C</span></p></td><td style="vertical-align:top;">
<p><span class="font7">30 detik/55 <sup>o</sup>C</span></p></td><td style="vertical-align:top;">
<p><span class="font7">201 bp</span></p></td><td style="vertical-align:top;">
<p><span class="font7">10</span></p></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:bottom;">
<p><span class="font7" style="font-style:italic;">Forward</span></p></td><td style="vertical-align:bottom;">
<p><span class="font7">GCA TAA GTC GCA ATC CCC G</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font7" style="font-style:italic;font-variant:small-caps;">B</span><span class="font7" style="font-style:italic;">la</span><span class="font8" style="font-style:italic;font-variant:small-caps;">ndm-1</span></p></td><td style="vertical-align:middle;">
<p><span class="font7" style="font-style:italic;">Reverse</span></p></td><td style="vertical-align:middle;">
<p><span class="font7">CTT CCT ATC TCG ACA TGC CG</span></p></td><td style="vertical-align:top;">
<p><span class="font7">30 detik/55 <sup>o</sup>C</span></p></td><td style="vertical-align:top;">
<p><span class="font7">237 bp</span></p></td><td style="vertical-align:top;">
<p><span class="font7">10</span></p></td></tr>
</table>
<p><span class="font10">Isolasi DNA bakteri menggunakan kit </span><span class="font10" style="font-style:italic;">High Pure Purification</span><span class="font10"> (Roche® </span><span class="font10" style="font-style:italic;">Singapore</span><span class="font10">), dan PCR dikerjakan menggunakan Go Green Taq (Promega®) sebanyak 35 kali siklus. Konsentrasi masing-masing primer </span><span class="font10" style="font-style:italic;">forward</span><span class="font10"> dan </span><span class="font10" style="font-style:italic;">reverse</span><span class="font10"> adalah 0,3 µL, sedangkan konsentrasi cetakan DNA yang digunakan sebesar 0,4 µL. Tahapan elektroforesis menggunakan agarose dengan konsentrasi 1%, selama 45 menit (</span><span class="font10" style="font-style:italic;">Electrophoresis system</span><span class="font10">, Mupid-Exu</span><span class="font11">™</span><span class="font10">).</span></p>
<h2><a name="bookmark8"></a><span class="font10" style="font-weight:bold;"><a name="bookmark9"></a>HASIL</span></h2>
<p><span class="font10">Kelima sampel isolat klinis </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> (pus [n=2]; urin [n=2]; lain-lain [n=1]) dari Instalasi Mikrobiologi Klinis RSUP Sanglah memperlihatkan profil multi-resisten</span></p>
<p><span class="font10">secara fenotip dengan uji Vitek Compact 2 (Biomeriux®). Tiga dari lima sampel yang diteliti menunjukan profil positif penghasil ESBL dengan uji fenotip.</span></p>
<p><span class="font10">Uji genotip menggunakan PCR didapatkan bahwa kelima sampel menunjukan adanya pita (</span><span class="font10" style="font-style:italic;">band</span><span class="font10">) positif pada gen penyandi 16s RNA. Gen penyandi ESBL ditemukan positif pada empat dari lima sampel penelitian. Dua sampel menunjukan adanya </span><span class="font10" style="font-style:italic;">co-existance</span><span class="font10"> antara gen bla</span><span class="font6">SHV </span><span class="font10">dan bla</span><span class="font6">TEM</span><span class="font10">, sementara gen tunggal bla</span><span class="font6">CTX-M </span><span class="font10">ditemukan positif pada dua sampel yang digunakan. Semua sampel menunjukan hasil negatif terhadap gen penyandi AmpC, dan karbapenemase (tabel 3).</span></p>
<p><span class="font10" style="font-weight:bold;">Tabel 2. </span><span class="font10">Profil Uji Sensitivitas Antibiotik Pada Isolat Klinis Multi-resistensi </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> di Laboratorium Mikrobiologi Klinik RSUP Sanglah.</span></p>
<table border="1">
<tr><td style="vertical-align:bottom;">
<p><span class="font8" style="font-weight:bold;">Nomor &nbsp;Profil</span></p>
<p><span class="font8" style="font-weight:bold;">isolat &nbsp;&nbsp;&nbsp;ESBL</span></p>
<p><span class="font8" style="font-weight:bold;">^ &nbsp;&nbsp;&nbsp;&nbsp;⅛ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;N &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;O &nbsp;&nbsp;&nbsp;&nbsp;.&amp; &nbsp;&nbsp;&nbsp;⅛ &nbsp;&nbsp;&nbsp;&nbsp;S &nbsp;&nbsp;g S JS</span></p>
<p><span class="font8" style="font-weight:bold;">U &nbsp;&nbsp;&nbsp;U &nbsp;&nbsp;&nbsp;&lt;&nbsp;&nbsp;&nbsp;&nbsp;^ &nbsp;&nbsp;&nbsp;U &nbsp;&nbsp;H &nbsp;&nbsp;Φ &nbsp;&lt;&nbsp;&lt;&nbsp;^</span></p></td><td style="vertical-align:bottom;">
<p><span class="font0" style="font-weight:bold;">S</span></p>
<p><span class="font0" style="font-weight:bold;">OJ s</span></p>
<p><span class="font0" style="font-weight:bold;">O</span></p>
<p><span class="font0" style="font-weight:bold;">OJ</span></p>
<p><span class="font0" style="font-weight:bold;">S</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font8">Ps–33 &nbsp;&nbsp;&nbsp;(+) &nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I &nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;R</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">R</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font8">Ps–55 &nbsp;&nbsp;(+) &nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;N/A &nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;N/A</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">R</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font8">L–66 &nbsp;&nbsp;&nbsp;&nbsp;(-) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;S &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;S &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;S &nbsp;&nbsp;&nbsp;N/A &nbsp;&nbsp;&nbsp;S &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">R</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font8">U–157 &nbsp;&nbsp;(+) &nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;S &nbsp;&nbsp;&nbsp;&nbsp;S &nbsp;&nbsp;&nbsp;N/A</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">R</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font8">U–166 &nbsp;&nbsp;(-) &nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;R &nbsp;&nbsp;&nbsp;&nbsp;R</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">R</span></p></td></tr>
</table>
<p><span class="font6">Keterangan :</span></p>
<p><span class="font6">Ps = Pus; L = Lain - lain; U = Urine; S = </span><span class="font6" style="font-style:italic;">Susceptible</span><span class="font6">; I = </span><span class="font6" style="font-style:italic;">Intermediet</span><span class="font6">; R = </span><span class="font6" style="font-style:italic;">Resistant</span><span class="font6">; N/A = </span><span class="font6" style="font-style:italic;">Not Available</span></p>
<p><span class="font3">2019</span></p>
<p><span class="font13">I</span><span class="font10">l—∖/—∖ </span><span class="font1" style="font-variant:small-caps;">λ</span><span class="font10"> &nbsp;&nbsp;j </span><span class="font1" style="font-variant:small-caps;">Directoryof</span></p>
<p><span class="font0" style="font-weight:bold;">OPEN ACCESS </span><span class="font10">I_√ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span class="font0" style="font-weight:bold;">JOURNALS</span></p>
<p><span class="font10" style="font-weight:bold;">Tabel 3</span><span class="font10">. Hasil PCR dengan primer 16s RNA, bla</span><span class="font6">SHV</span><span class="font10">, bla</span><span class="font6">TEM</span><span class="font10">, dan bla</span><span class="font6">CTX-M</span><span class="font10">, bla</span><span class="font6">FOX</span><span class="font10">, bla</span><span class="font6">KPC </span><span class="font10">dan bla</span><span class="font6">NDM-1 </span><span class="font10">pada Isolat Klinis Multi-resistensi </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> di Laboratorium Mikrobiologi Klinik RSUP Sanglah.</span></p>
<table border="1">
<tr><td rowspan="2" style="vertical-align:top;">
<p><span class="font8">Nomor Isolat</span></p></td><td rowspan="2" style="vertical-align:top;">
<p><span class="font8">16s RNA</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font8">ESBL</span></p></td><td style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;">
<p><span class="font8">AmpC (bla</span><span class="font5">FOX</span><span class="font8">)</span></p></td><td colspan="2" style="vertical-align:top;">
<p><span class="font8">Karbapenemase</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font8">bla</span><span class="font5">SHV</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">bla</span><span class="font5">TEM</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">bla</span><span class="font5">CTX-M</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">bla</span><span class="font5">KPC</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">bla</span><span class="font5">NDM-1</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font8">Ps–33</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">(+)</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">(+)</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font8">Ps–55</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">(+)</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">(+)</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font8">L–66</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">(+)</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">(+)</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">(+)</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font8">U–157</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">(+)</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">(+)</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">(+)</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">-</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font8">U–166</span></p></td><td style="vertical-align:middle;">
<p><span class="font8">(+)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font8">-</span></p></td><td style="vertical-align:bottom;">
<p><span class="font8">-</span></p></td><td style="vertical-align:bottom;">
<p><span class="font8">-</span></p></td><td style="vertical-align:bottom;">
<p><span class="font8">-</span></p></td><td style="vertical-align:bottom;">
<p><span class="font8">-</span></p></td><td style="vertical-align:bottom;">
<p><span class="font8">-</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font8">Total</span></p></td><td style="vertical-align:middle;">
<p><span class="font8" style="font-weight:bold;">(5/5)</span></p></td><td style="vertical-align:middle;">
<p><span class="font8" style="font-weight:bold;">2/5</span></p></td><td style="vertical-align:middle;">
<p><span class="font8" style="font-weight:bold;">2/5</span></p></td><td style="vertical-align:middle;">
<p><span class="font8" style="font-weight:bold;">2/5</span></p></td><td style="vertical-align:middle;">
<p><span class="font8" style="font-weight:bold;">0/5</span></p></td><td style="vertical-align:middle;">
<p><span class="font8" style="font-weight:bold;">0/5</span></p></td><td style="vertical-align:middle;">
<p><span class="font8" style="font-weight:bold;">0/5</span></p></td></tr>
</table>
<h2><a name="bookmark10"></a><span class="font10" style="font-weight:bold;"><a name="bookmark11"></a>PEMBAHASAN</span></h2>
<p><span class="font10">Hasil PCR terhadap 16s RNA menunjukan adanya pita dengan panjang basa 1,5 kilo bp pada semua sampel, sehingga disimpulkan bahwa semua sampel adalah isolat klinis </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10">. Empat dari lima sampel positif terhadap gen ESBL dengan uji genotip, namun terdapat satu sampel </span><span class="font10" style="font-style:italic;">false negative</span><span class="font10"> pada uji fenotip, yakni sampel nomor L–66 dengan gen bla</span><span class="font6">SHV </span><span class="font10">dan bla</span><span class="font6">TEM.</span></p>
<p><span class="font10" style="font-style:italic;">False negative</span><span class="font10"> ini juga ditemukan pada penelitian Tofteland dkk</span><span class="font0" style="font-weight:bold;"><sup>7</sup> </span><span class="font10">di Norwegia pada tahun 2003, dimana gen SHV-28 pada isolat </span><span class="font10" style="font-style:italic;">K. pneumoniae </span><span class="font10">memiliki aktivitas hidrolisis yang lemah terhadap </span><span class="font10" style="font-style:italic;">cefpodoxime </span><span class="font10">(MIC&lt;0.75mg/liter) sehingga memiliki interpretasi negatif pada uji fenotip. Selain itu, sensitivitas uji Vitek sebesar</span></p>
<p><span class="font10">73%, jika dibandingkan dengan sensitivitas </span><span class="font10" style="font-style:italic;">Disk Diffusion Test</span><span class="font10"> yang mencapai 96%.</span><span class="font0" style="font-weight:bold;"><sup>11,12</sup></span></p>
<p><span class="font10">Profil gen ESBL yang didapat dari hasil PCR menunjukan proporsi yang seimbang antara gen tunggal (bla</span><span class="font6">CTX-M</span><span class="font10">) dan gen multipel (bla</span><span class="font6">SHV </span><span class="font10">dan bla</span><span class="font6">TEM</span><span class="font10">). Hasil yang berbeda didapatkan dari penelitian sebelumnya yang dilakukan oleh Fatmawati dkk</span><span class="font0" style="font-weight:bold;"><sup>8</sup> </span><span class="font10">di RSUP Sanglah Denpasar tahun 2013 dan Goyal dkk</span><span class="font0" style="font-weight:bold;"><sup>13 </sup></span><span class="font10">di India tahun 2009 yang menyatakan bahwa profil ESBL positif didominasi oleh jumlah gen multipel (</span><span class="font10" style="font-style:italic;">co-existance</span><span class="font10">). Perbedaan ini terjadi karena jumlah sampel yang digunakan pada penelitian ini sangat terbatas.</span></p>
<p><span class="font10">Studi yang dilakukan oleh Pitout dkk</span><span class="font0" style="font-weight:bold;"><sup>14</sup> </span><span class="font10">pada tahun 2005 menyatakan bahwa gen bla</span><span class="font6">CTX-M </span><span class="font10">pada </span><span class="font10" style="font-style:italic;">E. coli </span><span class="font10">bertanggungjawab terhadap kasus</span></p>
<p><span class="font3">2019</span></p>
<div><a name="caption2"></a>
<h1><a name="bookmark12"></a><span class="font2"><a name="bookmark13"></a>DOAJ</span></h1>
</div><br clear="all">
<div>
<p><span class="font0" style="font-weight:bold;">DIRECTORY OF OPEN ACCESS JOURNALS</span></p>
</div><br clear="all">
<p><span class="font10">infeksi yang didapat dari komunitas, sedangkan gen bla</span><span class="font6">SHV </span><span class="font10">dan bla</span><span class="font6">TEM </span><span class="font10">lebih</span></p>
<p><span class="font10">banyak ditemukan pada kasus - kasus HAIs.</span><span class="font0" style="font-weight:bold;"><sup>3</sup> </span><span class="font10">Sesuai dengan hasil studi tersebut, gen tunggal bla</span><span class="font6">CTX-M </span><span class="font10">yang didapat dari isolat pus diidentifikasi</span></p>
<p><span class="font10">dengan sumber penyebaran di komunitas, sedangkan gen bla</span><span class="font6">SHV </span><span class="font10">dan bla</span><span class="font6">TEM </span><span class="font10">yang didapat dari isolat lain -lain dan urin menyebar melalui infeksi di rumah sakit.</span></p>
<p><span class="font10">Secara genotip AmpC ditemukan negatif pada semua sampel meskipun secara fenotip terdapat resistensi terhadap sefalosporin generasi ketiga dan amoksisilin-asam klavulanat pada</span></p>
<p><span class="font10">Amerika Serikat tahun 2002 menyatakan bahwa enzim AmpC dapat</span></p>
<p><span class="font10">dikode oleh gen selain bla</span><span class="font6">FOX </span><span class="font10">seperti bla</span><span class="font6">ACC</span><span class="font10">, bla</span><span class="font6">CMY</span><span class="font10">, bla</span><span class="font6">MOX</span><span class="font10">, bla</span><span class="font6">DHA</span><span class="font10">, bla</span><span class="font6">CIT, </span><span class="font10">dan bla</span><span class="font6">EBM</span><span class="font10">.</span></p>
<p><span class="font10">Begitu pula dengan kasus</span></p>
<p><span class="font10">resistensi terhadap karbapenem namun tidak ditemukan adanya gen bla</span><span class="font6">KPC </span><span class="font10">dan bla</span><span class="font6">NDM-1 </span><span class="font10">pada semua sampel penelitian. Hasil ini tidak bisa diklasifikasikan</span></p>
<p><span class="font10">sebagai </span><span class="font10" style="font-style:italic;">false positif,</span><span class="font10"> walaupun uji fenotip yang digunakan tidak menggunakan </span><span class="font10" style="font-style:italic;">Modified Hodge Test </span><span class="font10">(MHT) sesuai dengan panduan standar internasional.</span><span class="font0" style="font-weight:bold;"><sup>12</sup> </span><span class="font10">Banyak mekanisme lain yang dapat menyebabkan resistensi</span></p>
<div><img src="https://jurnal.harianregional.com/media/48606-1.jpg" alt="" style="width:411pt;height:154pt;">
</div><br clear="all">
<div><img src="https://jurnal.harianregional.com/media/48606-2.jpg" alt="" style="width:206pt;height:114pt;">
</div><br clear="all">
<div><img src="https://jurnal.harianregional.com/media/48606-3.jpg" alt="" style="width:205pt;height:114pt;">
</div><br clear="all">
<p><span class="font7" style="font-weight:bold;">Gambar 1. </span><span class="font7">(a) Hasil PCR 16s RNA dengan panjang basa 1,5 kilo bp; (b) Hasil PCR gen bla</span><span class="font8" style="font-variant:small-caps;">shv</span><span class="font7"> dengan panjang basa 862 bp; (c) Hasil PCR gen bla</span><span class="font8" style="font-variant:small-caps;">ctx-m</span><span class="font7"> dengan panjang basa 585 bp; (d) Hasil PCR gen bla</span><span class="font8" style="font-variant:small-caps;">ndm-1</span><span class="font7"> negatif pada semua sampel. Kolom M menandakan penanda (marker) dari kit PCR, sedangkan kolom (-) merupakan kontrol negatif yang digunakan.</span></p>
<p><span class="font10">Penelitian yang dilakukan oleh Giakkoupi dkk</span><span class="font0" style="font-weight:bold;"><sup>15</sup> </span><span class="font10">di Yunani pada tahun 2003 menyatakan bahwa &nbsp;&nbsp;&nbsp;kelas</span></p>
<p><span class="font10" style="font-style:italic;">Metallo-β-Lactamase</span><span class="font10"> lainnya selain bla</span><span class="font6">NDM</span><span class="font10">, yakni bla</span><span class="font6">VIM-1 </span><span class="font10">positif pada </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> dengan profil resistensi terhadap karbapenem. Selain itu, penelitian di Turki oleh Poirel dkk</span><span class="font0" style="font-weight:bold;"><sup>16 </sup></span><span class="font10">tahun 2003 menemukan bahwa enzim karbapenemase pada </span><span class="font10" style="font-style:italic;">K. pneumoniae </span><span class="font10">juga dikode oleh gen kelas D, yaitu bla</span><span class="font6">OXA-48</span><span class="font10">.</span></p>
<p><span class="font10">Adanya enzim ESBL dan AmpC ditambah modifikasi atau delesi dari protein membran luar (</span><span class="font10" style="font-style:italic;">Outer Membrane &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Protein &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;K.</span></p>
<p><span class="font10" style="font-style:italic;">pneumoniae/</span><span class="font10">OmpK) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;merupakan</span></p>
<p><span class="font10">mekanisme lain resistensi terhadap karbapenem.</span><span class="font0" style="font-weight:bold;"><sup>17</sup> </span><span class="font10">Mekanisme ini banyak diteliti oleh beberapa penelitian diantaranya oleh Wozniak dkk</span><span class="font0" style="font-weight:bold;"><sup>18</sup> </span><span class="font10">tahun 2011 di Chile yang menyatakan bahwa adanya gen ESBL pada hampir 90% sampel ditambah modifikasi atau delesi dari OmpK35 merupakan mekanisme resistensi terhadap karbapenem walaupun tidak ada gen karbapenemase yang dideteksi dengan PCR.</span></p>
<p><span class="font10">Penelitian yang dilakukan oleh Dahmen dkk</span><span class="font0" style="font-weight:bold;"><sup>19</sup> </span><span class="font10">di Tunisia pada tahun 2008 menggunakan isolat </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> Kp16137 menyimpulkan</span></p>
<p><span class="font10">bahwa profil resistensi terhadap karbapenem didapat akibat gen multipel (</span><span class="font10" style="font-style:italic;">co-existance</span><span class="font10">) bla</span><span class="font6">TEM</span><span class="font10">, bla</span><span class="font6">SHV</span><span class="font10">, dan bla</span><span class="font6">CMY </span><span class="font10">ditambah delesi OmpK36.</span></p>
<p><span class="font10">Penelitian yang dilakukan oleh Chiu dkk</span><span class="font0" style="font-weight:bold;"><sup>20</sup> </span><span class="font10">pada tahun 2012 di Taiwan juga menegaskan mekanisme utama resistensi terhadap karbapenem adalah adanya ko-eksistensi gen ESBL, AmpC, dan delesi OmpK35/36. Meskipun ditemukan adanya total prevalensi gen bla</span><span class="font6">KPC</span><span class="font10">, bla</span><span class="font6">NDM </span><span class="font10">dan bla</span><span class="font6">VIM </span><span class="font10">sebesar 22,3%, namun penyebab resistensi karbapenem diakibatkan karena ko-eksistensi gen ESBL/AmpC ditambah delesi OmpK35/36 masing– masing sebesar 90% dan 95%.</span></p>
<h2><a name="bookmark14"></a><span class="font10" style="font-weight:bold;"><a name="bookmark15"></a>SIMPULAN</span></h2>
<p><span class="font10">Sifat resistensi antibiotik golongan β-lactam, asam klavulanat dan sefalosporin dari uji fenotip pada penelitian ini kemungkinan disebabkan oleh adanya gen penyandi ESBL. Adapun resistensi terhadap karbapenem kemungkinan disebabkan oleh mekanisme resistensi lain, dan bukan akibat adanya gen penyandi karbapenemase.</span></p>
<p><span class="font10">Diperlukan penelitian lanjutan untuk mengetahui mekanisme resistensi terhadap karbapenem pada isolat klinis </span><span class="font10" style="font-style:italic;">K. pneumoniae</span><span class="font10"> di RSUP</span></p>
<p><span class="font10">Sanglah, Denpasar. Penelitian yang melibatkan jumlah sampel yang lebih banyak dalam kurun waktu tertentu, mencakup gen karbapenemase di seluruh kelas (A, B, dan D), dan menganalisis profil dari protein membran OmpK.</span></p>
<h2><a name="bookmark16"></a><span class="font10" style="font-weight:bold;"><a name="bookmark17"></a>UCAPAN TERIMA KASIH</span></h2>
<p><span class="font10">Peneliti mengucapkan terimakasih banyak terhadap semua pihak yang membantu, terutama Laboratorium Mikrobiologi FK UNUD, Bagian/SMF Mikrobiologi FK UNUD/RSUP Sanglah, serta Instalasi Mikrobiologi Klinis RSUP Sanglah. Peneliti tidak memiliki konflik kepentingan apapun dalam penelitian ini.</span></p>
<h2><a name="bookmark18"></a><span class="font10" style="font-weight:bold;"><a name="bookmark19"></a>DAFTAR PUSTAKA</span></h2>
<ul style="list-style:none;"><li>
<p><span class="font8">1. &nbsp;&nbsp;&nbsp;Center for Disease Control and Prevention (CDC). </span><span class="font8" style="font-style:italic;">Antibiotic Resistance Threats in the United Status</span><span class="font8">. CDC Publisher. 2013. Tersedia pada</span><a href="http://www.cdc.gov/"><span class="font8"> </span><span class="font8" style="text-decoration:underline;">www.cdc.gov</span><span class="font8"> </span></a><span class="font8">[diakses pada 10 Desember 2014]</span></p></li>
<li>
<p><span class="font8">2. &nbsp;&nbsp;&nbsp;World Health Organization (WHO). </span><span class="font8" style="font-style:italic;">Antimicrobial Resistance Global Report on Surveillance</span><span class="font8">. &nbsp;&nbsp;&nbsp;2014. Tersedia pada</span></p></li></ul>
<p><a href="http://www.who.org/"><span class="font8" style="text-decoration:underline;">www.who.org</span><span class="font8"> </span></a><span class="font8">[diakses pada 2 Desember 2014]</span></p>
<ul style="list-style:none;"><li>
<p><span class="font8">3. &nbsp;&nbsp;&nbsp;Pitout JD dkk. </span><span class="font8" style="font-style:italic;">Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community</span><span class="font8">. Journal of Antimicrobial Chemotherapy. 2005;56.</span></p></li>
<li>
<p><span class="font8">4. &nbsp;&nbsp;&nbsp;Kanj, Souha S dan Kanafani Zeina A. </span><span class="font8" style="font-style:italic;">Current Concepts in Antimicrobial Therapy Against Resistant Gram – Negative Organism : Extended – Serum β – Lactamase Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug – Resistant Pseudomonas Aeruginosa</span><span class="font8">. Symposium on Antimicrobial</span></p></li></ul>
<p><span class="font8">Therapy, Mayo Clinic Proceedings. 2011; 86 (3):250 – 259.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font8">5. &nbsp;&nbsp;&nbsp;Nordmann, Patrice dkk. </span><span class="font8" style="font-style:italic;">Global Spread of Carbapenamase &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;– &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;producing</span></p></li></ul>
<p><span class="font8" style="font-style:italic;">Enterobacteriaceae</span><span class="font8">. Journal of Emerging Infectious Disease. 2011; 17:1791 – 1798.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font8">6. &nbsp;&nbsp;&nbsp;Weisburg, W. G., S. M. Barns, D. A. Pelletier, and D. J. Lane. </span><span class="font8" style="font-style:italic;">16S ribosomal DNA amplification for phylogenetic study. </span><span class="font8">J. Bacteriol.1991;173:697– 703.</span></p></li>
<li>
<p><span class="font8">7. &nbsp;&nbsp;&nbsp;Tofteland, Stale dkk. </span><span class="font8" style="font-style:italic;">Effects of Phenotype and Genotype on Methods for Detection of Extended – Serum β – Lactamase Producing Clinical Isolates of Escherichia coli and Klebsiella pneumoniae in Norway</span><span class="font8">. Journal of Clinical Microbiology. 2007; 45(1):199-205.</span></p></li>
<li>
<p><span class="font8">8. &nbsp;&nbsp;&nbsp;Fatmawati, Dwi dkk. </span><span class="font8" style="font-style:italic;">Molecular Characterization of Extended – Spectrum β-Lactamase-producing &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Klebsiella</span></p></li></ul>
<p><span class="font8" style="font-style:italic;">pneumoniae isolated from clinical specimens at a tertiary-referral hospital in Denpasar, Bali, Indonesia</span><span class="font8">. Journal of Advanced Science Letters. 2014.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font8">9. &nbsp;&nbsp;&nbsp;Perez FJP, Hanson ND. </span><span class="font8" style="font-style:italic;">Detection of Plasmid-Mediated AmpC Lactamase Genes in Clinical Isolates by Using Multiplex PCR.</span><span class="font8"> Journal of Clinical Microbiology. 2002; 40 (6):2153 – 2162.</span></p></li>
<li>
<p><span class="font8">10. &nbsp;&nbsp;&nbsp;Solanki, Rachana dkk. </span><span class="font8" style="font-style:italic;">Comparative Evaluation of Multiplex PCR and Routine Laboratory Phenotypic Methods for Detection of Carbapenemases among Gram Negative Bacilli.</span><span class="font8"> Journal of Clinical and Diagnostic Research. 2014; 8 (12):23 – 26.</span></p></li>
<li>
<p><span class="font8">11. &nbsp;&nbsp;&nbsp;Garrec, Helena dkk. </span><span class="font8" style="font-style:italic;">Comparison of Nine Phenotypic Methods for Detection of Extended-Spectrum Lactamase Production by Enterobacteriaceae.</span><span class="font8"> Journal of Clinical Microbiology. 2011; 49 (3):1048-1057.</span></p></li>
<li>
<p><span class="font8">12. &nbsp;&nbsp;&nbsp;Control and Laboratory Standards Institute (CLSI). </span><span class="font8" style="font-style:italic;">Performance Standards for Antimicrobial Susceptibility Testing; Twenty – Second Informational Supplement</span><span class="font8">. 2012; 32 (3). Tersedia pada </span><a href="http://www.clsi.org/"><span class="font8" style="text-decoration:underline;">www.clsi.org</span><span class="font8"> </span></a><span class="font8">[diakses pada 20 Desember 2014]</span></p></li>
<li>
<p><span class="font8">13. &nbsp;&nbsp;&nbsp;Goyal A, dkk. </span><span class="font8" style="font-style:italic;">Extended – Spectrum β-Lactamase in Escherichia coli and Klebsiella pneumoniae &amp;&nbsp;Associated Risk Factors</span><span class="font8">. Indian Journal of Medical Research. 2009; 129: 695-700.</span></p></li></ul>
<p><span class="font3">2019</span></p>
<div>
<h1><a name="bookmark20"></a><span class="font2"><a name="bookmark21"></a>DOAJ</span></h1>
</div><br clear="all">
<div>
<p><span class="font0" style="font-weight:bold;">DIRECTORY OF OPEN ACCESS JOURNALS</span></p>
</div><br clear="all">
<ul style="list-style:none;"><li>
<p><span class="font8">14. &nbsp;&nbsp;&nbsp;Pitout JD, &nbsp;Laupland KB. </span><span class="font8" style="font-style:italic;">Extended-</span></p></li></ul>
<p><span class="font8" style="font-style:italic;">spectrum &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;β-lactamase–producing</span></p>
<p><span class="font8" style="font-style:italic;">Enterobacteriaceae: an emerging public health concern</span><span class="font8">. Lancet Infect Dis. 2008;8:159–66. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;doi:10.1016/S1473-</span></p>
<p><span class="font8">3099(08)70041-0.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font8">15. &nbsp;&nbsp;&nbsp;Giakkoupi P, dkk. &nbsp;</span><span class="font8" style="font-style:italic;">VIM-1 &nbsp;Metallo-β-</span></p></li></ul>
<p><span class="font8" style="font-style:italic;">Lactamase-Producing Klebsiella pneumonia Strains in Greek Hospitals</span><span class="font8">. Journal of Clinical Microbiology. 2003; 41 (8):3893-3896.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font8">16. &nbsp;&nbsp;&nbsp;Poirel, Laurent dkk. </span><span class="font8" style="font-style:italic;">Carbapenamases: Molecular Diversity and Clinical Consequences.</span><span class="font8"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Journal &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Future</span></p></li></ul>
<p><span class="font8">Microbiology. 2007; 2 (5):501-512.</span></p>
<ul style="list-style:none;"><li>
<p><span class="font8">17. &nbsp;&nbsp;&nbsp;Pages, Jean – Marie dkk. </span><span class="font8" style="font-style:italic;">The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria</span><span class="font8">. Journal of Nature Reviews Microbiology. 2008; 6.</span></p></li>
<li>
<p><span class="font8">18. &nbsp;&nbsp;&nbsp;Wozniak, Aniela dkk. </span><span class="font8" style="font-style:italic;">Porin alterations present in non carbapenemase producing Enterobacteriaceae with high and intermediate levels of carbapenem resistance in Chile</span><span class="font8">. Journal of Medical Microbiology. 2012; 61:1270 – 1279.</span></p></li>
<li>
<p><span class="font8">19. &nbsp;&nbsp;&nbsp;Dahmen, Safia dkk. </span><span class="font8" style="font-style:italic;">Imipenem Resistance in Klebsiella Pneumoniae is Associated to the Combination of Plasmid – Mediated CMY-4 AmpC β-Lactamase and Loss of an Outer Membrane Porin</span><span class="font8">. Journal of Microbial Drug Resistance. 2012; 18 (5).</span></p></li>
<li>
<p><span class="font8">20. &nbsp;&nbsp;&nbsp;Chiu, Sheng-Kang dkk. </span><span class="font8" style="font-style:italic;">National Surveillance Study on Carbapenem Non – Susceptible Klebsiella pneumoniae in Taiwan : The Emergence and Rapid Dissemination of KPC – 2 Carbapenamase. </span><span class="font8">2012. Tersedia pada</span><a href="http://www.plosone.org/"><span class="font8"> </span><span class="font8" style="text-decoration:underline;">www.plosone.org</span></a><span class="font8" style="text-decoration:underline;"> </span><span class="font8">[diakses pada 21 Desember 2014]</span></p></li></ul>
<p><a href="https://ojs.unud.ac.id/index.php/eum"><span class="font3">https://ojs.unud.ac.id/index.php/eum</span></a></p>